Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novocure Ltd Ord Sh
(NQ:
NVCR
)
19.44
-0.31 (-1.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novocure Ltd Ord Sh
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
16
17
Next >
Novocure to Participate in 41st Annual J.P. Morgan Healthcare Conference
December 27, 2022
From
Novocure
Via
Business Wire
3 Stocks That Could Soar in a Santa Claus Rally
December 25, 2022
These stocks are primed for a holiday surge.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
December 23, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
3 Top Stocks to Buy Hand Over Fist Before the End of 2022
December 12, 2022
You probably shouldn't wait for long to buy these stocks.
Via
The Motley Fool
Where NovoCure Stands With Analysts
November 29, 2022
Via
Benzinga
Why Novocure Stock Is Jumping Today
November 29, 2022
Novocure's innovative cancer therapy picked up a big win in Canada.
Via
The Motley Fool
5 Analysts Have This to Say About NovoCure
November 29, 2022
Via
Benzinga
Novocure Stock: Bull vs. Bear
November 26, 2022
The company's technology has a lot of potential. But does its stock?
Via
The Motley Fool
5 Top Stocks for December
December 04, 2022
From game-changing products to indisputable growth catalysts, this list of top stocks has something for all.
Via
The Motley Fool
12 Top Stocks to Buy in December
December 03, 2022
Add this dandy dozen to your stocking this month.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2022
November 29, 2022
Via
Benzinga
Novocure’s Optune® Approved in Canada for the Treatment of Newly Diagnosed and Recurrent Glioblastoma
November 29, 2022
From
Novocure
Via
Business Wire
What 4 Analyst Ratings Have To Say About NovoCure
October 28, 2022
Analysts have provided the following ratings for NovoCure (NASDAQ:NVCR) within the last quarter:
Via
Benzinga
Where NovoCure Stands With Analysts
October 28, 2022
NovoCure (NASDAQ:NVCR) has observed the following analyst ratings within the last quarter:
Via
Benzinga
FedEx To Rally Over 25%? Here Are 10 Other Price Target Changes For Tuesday
November 29, 2022
Keybanc lowered Salesforce, Inc. (NYSE: CRM) price target from $210 to $200. . Keybanc analyst Michael Turits maintained an Overweight rating on the stock. Salesforce shares gained 0.5% to $154.45 in...
Via
Benzinga
3 Growth Stocks to Buy That Could Skyrocket
November 28, 2022
The future looks promising for all three of these stocks.
Via
The Motley Fool
Novocure to Participate in 34th Annual Piper Sandler Healthcare Conference
November 23, 2022
From
Novocure
Via
Business Wire
Novocure Announces 25 Abstracts on Tumor Treating Fields Therapy at Society for Neuro-Oncology 2022 Annual Meeting
November 17, 2022
From
Novocure
Via
Business Wire
Novocure (NVCR) Q3 2022 Earnings Call Transcript
October 27, 2022
NVCR earnings call for the period ending September 30, 2022.
Via
The Motley Fool
Why Novocure Stock Is Sinking Today
October 24, 2022
An analyst's downgrade is weighing on the biotech company.
Via
The Motley Fool
Novocure Opens Office in Montreal to Expand and Support Growing Business in Canada
November 15, 2022
From
Novocure
Via
Business Wire
Novocure Secures CE Mark for New Array
November 11, 2022
From
Novocure
Via
Business Wire
2 Potentially Explosive Stocks to Buy in November
November 08, 2022
Both Novocure and MercadoLibre could have good news on the way.
Via
The Motley Fool
NovoCure's Return On Capital Employed Insights
November 02, 2022
NovoCure (NASDAQ:NVCR) brought in sales totaling $131.00 million during Q3 according to data provided by Benzinga Pro. However, earnings decreased 10.7%, resulting in a loss of $26.58 million.
Via
Benzinga
3 Unstoppable Stocks That Could Double in 5 Years
October 29, 2022
The opportunities for these innovators are tremendous.
Via
The Motley Fool
NovoCure: Q3 Earnings Insights
October 27, 2022
NovoCure (NASDAQ:NVCR) reported its Q3 earnings results on Thursday, October 27, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings NovoCure beat estimated earnings...
Via
Benzinga
Novocure Reports Third Quarter 2022 Financial Results
October 27, 2022
From
Novocure
Via
Business Wire
CSX To Rally 20%? Here Are 5 Other Price Target Changes For Monday
October 24, 2022
Raymond James raised CSX Corporation (NASDAQ: CSX) price target from $31 to $33. Raymond James analyst Patrick Tyler Brown maintained the stock with an Outperform rating. CSX shares rose 1.7% to close...
Via
Benzinga
Novocure Announces 11 Presentations on Tumor Treating Fields in Multiple Solid Tumor Types at the American Society for Radiation Oncology 2022 Annual Meeting
October 21, 2022
From
Novocure
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2022
October 24, 2022
Upgrades
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.